Paramount Advantage Formulary Specialty Pharmacy List



Similar documents
Specialty Drug Program RX Benefit Member Guide

MEDICAL ASSISTANCE BULLETIN

Alameda Alliance for Health SPECIALTY PHARMACY PROGRAM FOR ALLIANCE MEDI-CAL AND GROUP CARE MEMBERS PROGRAM DESCRIPTION

Self-injectable, infused and oral specialty drugs 2014 Aetna Specialty CareRx SM Benefits Plan Drug List

STAT Bulletin. Drug Therapy Guideline Updates. May 11, 2012 Volume: 18 Issue: 12

N/A N/A N/A. Supporting statement of diagnosis from the N/A. physician and documented trial of 1 generic. formulary alternative

CONNECTICARE, INC. & AFFILIATES

Pain management for cancer patients Acute Ischemic Stroke. Hemophilia, Von willebrand disease & Bleeding disorders. Infectious Disease

Local Coverage Article: Self-Administered Drug Exclusion List (A51866)

Prescription Drug Benefit Description

Specialty drug trend

Provider Manual. This manual is to help you learn more about The Ohio State University s medical plans, administered by OSU Health Plan Inc.

Drugs Requiring Prior Authorization. Olysio. Subsys. Prolia. Tecfidera

Specialty Pharmacy: Understanding the Market and Solution. Your Goals. Presented by Chris Brown November 2009

encourages correct prescription drug use for a particular diagnosis, promotes the safe use of prescription drugs, and helps reduce drug costs.

2016 MDwise HIP Medical Services that Require Prior Authorization

COVERAGE MANAGEMENT PROGRAMS

Great-West s Drug Prior Authorization

2016 MDwise HIP Medical Services that Require Prior Authorization

22 Medicare Provider Manual

Humana 2015 Autorización previa

Filtration Guidelines for the Administration of Intravenous Medications UK Pharmacy Services Revised 8/2010

PATIENT ASSISTANCE PROGRAMS

Prescription Drug Benefit

Rheumatic Diseases, Psoriasis, and Crohn s Disease

Brand Generic J-Code Covered Uses Required Medical Information and Criteria

Special Authorization

January 1, 2016 At A Glance. CSEA Civil Service Employees Association

ACTEMRA. Cigna Medicare Rx (PDP) 2014 Cigna Medicare Rx Secure Plan (PDP) Formulary. Products Affected Actemra. Prior Authorization Criteria

ICORE Healthcare: Injectable Drug Utilization Management Program Overview for EmblemHealth Providers. May 1, 2012

Commercial Medicines Unit

Effective: July 28, Arizona Prior Authorization Requirements Health Net Access, Inc.

Medical School for Actuaries. June 12, Baltimore, Maryland

Review of the List of High-Cost Medicines used by the Dominican Republic s Protected Diseases Program and Planning of Purchases for 2015

Items Covered Benefit for Preferred Vendor Contact Information. Medicaid ONLY Integra Phone

Drugs That Require Prior Authorization (PA) Before Being Approved for Coverage PRIOR AUTHORIZATION MEDICATIONS

Immune Modulating Drugs Prior Authorization Request Form

NDC HCPCS HCPCS Description NDC Description Effective Date End Date X-Over Only

4Precertification. and Referrals. Precertification...59 Referrals (Gated Plans Only)...73

MEDICAL BENEFIT BOOKLET

INPATIENT SERVICES Commercial Medicare. Notification required only, as soon as possible, but no later than 24 hours

Specialty Pharmacy Program Drug List

REFERRAL/AUTHORIZATION GUIDELINES Commercial Plans

2013 Prior Authorization (PA) Criteria

Effective Date: 6/3/14

Prior Authorization Criteria 2014

SPECIAL AUTHORIZATION GUIDELINES

BCBSNM Drug List Limitations, Exclusions, and Preauthorization Criteria

PULMONARY ARTERIAL HYPERTENSION AGENTS

Development of the market of special care drugs

Medi-Cal Expansion, Mental Health Services and Changes to Medi-Cal Prior Authorization Requirements

Medical Prior Authorization List For prescription drug requirements, see plan formularies.

10/10/2008. Orphan drugs. Orphan drugs. Legislation Prevalence and evolution Slicing Cost. Raw materials Rare diseases: capita selecta Conclusions

Fourth Quarter 2014 Provider Connection

Pharmacotherapy of Autoimmune Disorders

Multiple Sclerosis Step Therapy and Quantity Limit Criteria

PATIENT APPLICATION FORM INSTRUCTIONS

Multiple Sclerosis Center of Nebraska

Non-urgent Pre-service requests---within 3 business days of receipt of request. Urgent Pre-service requests---within 72 hours of receipt of request

January 1, Participating Agencies

Quantum of Effectiveness Evidence in FDA s Approval of Orphan Drugs

New Oral Chemotherapeutic Agents: Part B vs. Part D Implications

Meridian Health Plan Drugs Covered under the Medical Benefit* Updated 09/2015 PA Required

Drug List Limitations, Exclusions and Preauthorization Criteria

Participating Provider Precertification List

1. Phosphodiesterase Type 5 Enzyme Inhibitors: Sildenafil (Revatio), Tadalafil (Adcirca)

Prescription Drug Summary Plan Description

ACNE PRODUCTS. Affected Drugs: Epiduo Retin-A Tretinoin. Covered Uses: All FDA-approved indications not otherwise excluded from Part D

Prior Authorization FID VER.7 UPDATED 8/2015

Specialty Pharmacy. Business Plan. July 8, RUSH University Medical Center

Inventory of Access and Prices of Orphan Drugs across Europe:

Prescription Access resources. NeedyMeds. RxAssist.org. Together RX Access TogetherRxAccess.com

Health Choice Arizona

UMASTER PREFERRED DRUG LIST (DRUG FORMULARY) Effective July 1, 2015 RA05/15.654

2016 Medicaid Preapproval Criteria

ACTEMRA. Products Affected. Actemra

All FDA-approved indications not otherwise excluded from Part D. Plus patients already started on tocilizumab for a Covered Use.

New Mexico Drug Donation Guide

Student Employee Health Plan (SEHP) for Graduate Student Employees

Commonwealth of Massachusetts Executive Office of Health and Human Services Office of Medicaid

ACS CAN Examination of Cancer Drug Coverage and Transparency in the Health Insurance Marketplaces

Pharmaceutical Risk Sharing Agreements C. Bernie Good MD MPH Department of Veterans Affairs June 2014

Sector Analysis February 4, 2016

Kaiser Permanente s Evaluation And Management Of Biotech Drugs: Assessing, Measuring, And Affecting Use

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Manufacturer of drug substance

drug trend and therapy class review CuraScript Specialty Pharmacy Management Guide & Trend Report

Prior authorization. (a) Any medical service may be placed by the

Prior Authorization Requirements Effective: 12/01/2015

Excluded Drug Criteria. Coverage Duration. Age Restrictions. Prescriber Restrictions. Prior Authorization Type Description.

Building A Fully Integrated Biotech Company:

Transcription:

Paramount Advantage Formulary Specialty Pharmacy List Note: When these products are self-administered they are covered as part of the Paramount Advantage pharmacy benefit, and should be obtained at a pharmacy that is part of Paramount's Specialty Pharmacy Network. Brand Name Generic Name Brand Name Generic Name Antiviral PA Growth Disorder PA Copegus ribavirin Sandostatin octreotide Fuzeon enfuviritide Somatuline Depot lanreotide Hepsera adefovir Somavert pegvisomant Incivek telapravir Infergen interferon alfacon-1 Growth Hormone PA Intron A interferon alpha-2b Accretropin somatropin Pegasys peginterferon alfa-2a Genotropin somatropin PEG-Intron peginterferon alfa-2b Geref sermorelin acetate Rebetol ribavirin Humatrope human growth hormone Rebetron interferon alfa-2b Increlex mecasermin RibaPak ribavirin Norditropin somatropin Ribasphere ribavirin Nutropin somatropin Roferon A interferon alfa-2a Nutropin AQ somatropin Virazole ribavirin Omnitrope somatropin Sylatron peginterferon alfa-2b Saizen somatropin Synagis palivizumab Serostim somatropin Victrelis boceprevir Tev-tropin somatropin Zorbtive somatropin Autoimmune Disorders PA Actemra tocilizumab Hemophilia Benlysta belimumab Advate Factor VIII (recomb) Cimzia certolizumab pegol Alphanate Factor VIII (human) Enbrel etanercept Alphanate/vWF Factor VIII (human)/vwf Humira adalimumab Alphanine SD Factor IX (human) Kineret anakinra Bebulin VH Factor IX complex (human) Orencia abatacept Benefix Factor IX (recomb) Remicade infliximab Feiba VH apcc Factor VIII Rituxan rituximab Genarc Factor VIII (recomb) Simponi golimumab Helixate FS Factor VIII (recomb) Hemofil-M Factor VIII (human) Colony Stimulating Factors Humate-P Factor VIII/vWF (human) Leukine sargramostim Koate-DVI Factor VIII (human) Mozobil PA plerixafor Kogenate FS Factor VIII (recomb) Neulasta PA pegfilgrastim Monoclate-P Factor VIII (human) Neupogen filgrastim Mononine Factor IX (human) Novoseven RT Factor VIIa (recomb) Erythropoiesis-Stimulating Agents PA Profilnine SD Factor IX complex (human) Aranesp darbepoetin alfa Proplex T Factor IX (human) Epogen epoetin alfa Recombinate Factor VIII (recomb) Procrit epoetin alfa Refacto Factor VIII (recomb) Wilate Factor VIII/vWF (human) Growth Factor (Human) Xyntha Factor VIII (recomb) Neumega oprelvekin (ril-11) Specialty drugs include both brand-name drug and any generic equivalent. The list is subject to change without notice. Page 1 PA Prior Authorization based on clinical criteria required prior to payment Revised: 2011-Sept

Paramount Advantage Formulary Specialty Pharmacy List Brand Name Generic Name Brand Name Generic Name Immune Deficiency Multiple Indications Atgam lymphocyte immune globulin Actimmune PA interferon gamma-1b Carimune NF PA IVIG lyophilized Depo-testosterone testosterone cypionate Flebogamma DIF PA IVIG nonlyophilized Lupron PA leuprolide Gammagard PA immune globulin Lupron Depot PA leuprolide depot Gammaplex PA immune globulin Recothrom PA topical thrombin Gamunex PA or Gamunex C PA IVIG nonlyophilized Hizentra PA SubQ immune globulin Multiple Sclerosis PA Privigen PA immune globulin Ampyra dalfampirdine Thymoglobulin immune globulin (rabbit) Avonex interferon beta-1a Vivaglobin PA SubQ immune globulin Betaseron interferon beta-1b Copaxone glatiramer acetate Extavia interferon beta-1b Rebif interferon beta-1a Stelara ustekinumab Metabolic Bone Disorder PA Tysabri natalizumab Sensipar cinacalcet Forteo teriparatide Oncology Prolia denusomab Afinitor PA everolimus Eligard PA leuprolide Emcyt PA estramustine Metabolic Disorders Gleevec PA imatinib Adagen PA (orphan drug) pegademase bovine Hycamtin PA (oral) topotecan Aldurazyme PA laronidase Iressa PA gefitinib Arcalyst PA rilonacept Lupron PA leuprolide Berinert PA C1-esterase inhibitor Lupron Depot PA leuprolide depot Buphenyl sodium phenylbutyrate Nexavar PA sorafenib Ceredase PA aglucerase Novantrone PA mitoxantrone Cerezyme PA imiglucerase Panretin PA (orphan drug) alitretinoin 0.1% gel Cinryze PA C1-esterase inhibitor Revlimid PA lenalidomide Desferal PA deferoxamine Sandostatin PA octreotide Elaprase PA idursulfase Sandostatin Depot PA octreotide depot Exjade PA deferasirox Sprycel PA dasatinib Fabrazyme PA agalsidase beta Sutent PA sunitinib Ganirelix PA ganirelix Tarceva PA erlotinib Myozyme PA alglucosidase alfa Targretin PA bexarotene Nplate PA romiplostim Tasigna PA nilotinib Orfadin PA nitisinone Temodar PA temozolomide Promacta PA eltrombopag Thalomid PA thalidomide Samsca PA tolvaptan Tykerb PA lapatinib Soliris PA eculizumab Vandetanib PA vandetanib Sucraid PA sacrosidase Toposar etoposide Vivitrol naltrexone Vesanoid PA tretinoin Xenazine PA tetrabenazine Xeloda PA capecitabine Zavesca PA miglustat Zolinza PA vorinostat Specialty drugs include both brand-name drug and any generic equivalent. The list is subject to change without notice. Page 2 PA Prior Authorization based on clinical criteria required prior to payment Revised: 2011-Sept

Paramount Advantage Formulary Specialty Pharmacy List Brand Name Generic Name Brand Name Generic Name Neurological/Muscular Disorders Pulmonary Hypertension PA Apokyn apomorphine Adcirca tadalafil Botox PA botulinum toxin type A Flolan epoprostenol H.P. Acthar PA corticotropin Letairis ambrisentan Myobloc PA botulinum toxin type B Remodulin treprostinil Rilutek PA riluzole Revatio sildenafil Xeomin PA incobotulinumtoxin A Tracleer bosentan Xyrem PA sodium oxybate Tyvaso treprostinil inhaled Ventavis iloprost Psoriasis PA Respiratory Disorders PA 8-MOP systemic methoxsalen Aralast (NP) alpha, antitrypsin Amevive alefacept Glassia alpha-1 proteinase inhibitor Soriatane acitretin Prolastin alpha, antitrypsin Xolair omalizumab Zemaira alpha, antitrypsin Specialty drugs include both brand-name drug and any generic equivalent. The list is subject to change without notice. Page 3 PA Prior Authorization based on clinical criteria required prior to payment Revised: 2011-Sept

Paramount Medicaid Formularies Specialty Pharmacy Alphabetical Listing Brand Name (generic) criteria Brand Name (generic) criteria 8-MOP (systemic methoxsalen) PA Desferal (deferoxamine) PA Accretropin (somatropin rdna) PA Elaprase (idursulfase) PA Actemra (tocilizumab) PA Eligard (leuprolide) PA Actimmune (interferon gamma-1b) PA Emcyt (estramustine) PA Adagen (pegademase bovine) PA Enbrel (etanercept) PA Adcirca (tadalafil) PA Epogen (erythropoietin) PA Advate (Factor VIII) Exjade (deferasirox) PA Afinitor (everolimus) PA Extavia (interferon beta-1b) PA Aldurazyme (laronidase) PA Fabrazyme (agalsidase beta) PA Alphanate (Factor VIII) Feiba VH (apcc Factor VIII) Alphanate/vWF (Factor VIII/vWF) Flebogamma DIF (IVIG nonlyophilized) PA Alphanine SD (Factor IX) Flolan (generic epoprostenol) PA Amevive (alefacept) PA Forteo (teriparatide) PA Ampyra (dalfampirdine) PA Fuzeon (enfuviritide) PA Apokyn (apomorphine) Gammagard (immune globulin) PA Aralast NP (alpha1-proteinase inhibitor) PA Gammaplex (immune globulin) PA Aranesp (darbepoetin alfa) PA Gamunex (IVIG nonlyophilized) PA Arcalyst (rilonacept) PA Gamunex C (IVIG nonlyophilized) PA Atgam (lymphocyte immune globulin (equine)) Ganirelix (ganirelix) PA Avonex (interferon beta-1a) PA Genarc (Factor VIII) Bebulin VH (Factor IX complex) Genotropin (somatropin) PA Benefix (Factor IX) Geref (sermorelin acetate) PA Benlysta (belimumab) PA Glassia (alpha-1 proteinase inhibitor) PA Berinert (C1 esterase inhibitor) PA Gleevec (imatinib) PA Betaseron (interferon beta-1b) PA H.P. Acthar (corticotropin) PA Botox (botulinum toxin type A) PA Helixate FS (Factor VIII) Buphenyl (sodium phenylbutyrate) Hemofil-M (Factor VIII) Carimune NF (IVIG lyopholized) PA Hepsera (adefovir) PA Ceredase (aglucerase) PA Hizentra (IVIG) PA Cerezyme (imiglucerase) PA Humate-P (Factor VIII/vWF) Cimzia (certolizumab) PA Humatrope (human growth hormone) PA Cinryze (C1-esterase inhibitor) PA Humira (adalimumab) PA Copaxone (glatiramer acetate) PA Hycamtin (topotecan) PA Copegus (ribavirin) PA Incivek (telapravir) PA Depo-testosterone (testosterone cypionate) Increlex (mecasermin) PA Specialty drugs include both brand-name drug and any generic equivalent. List is subject to change without notice. Page 4 PA Prior Authorization based on clinical criteria required prior to payment 2011-Sept

Paramount Medicaid Formularies Specialty Pharmacy Alphabetical Listing Brand Name (generic) criteria Brand Name (generic) criteria Infergen (interferon alfacon-1) PA Prolastin (alpha1-proteinase inhibitor) PA Intron A (interferon alpha-2b) PA Prolia (denosumab) PA Iressa (gefitinib) PA Promacta (eltrombopag) PA Kineret (anakinra) PA Proplex T (Factor IX) Koate-DVI (Factor VIII) Rebetol (ribavirin) PA Kogenate FS (Factor VIII) Rebetron (interferon alfa-2b ) PA Letairis (ambrisentan) PA Rebif (interferon beta-1a) PA Leukine (sargramostim) Recombinate (Factor VIII) Lupron (leuprolide) PA Recothrom (topical thrombin) PA Lupron Depot (leuprolide depot) PA Refacto (Factor VIII) Monoclate-P (Factor VIII) Remicade (infliximab) PA Mononine (Factor IX) Remodulin (treprostinil) PA Mozobil (plerixafor) PA Revatio (sildenafil) PA Myobloc (botulinum toxin type B) PA Revlimid (lenalidomide) PA Myozyme (alglucosidase alfa) PA RibaPak (ribavirin) PA Neulasta (pegfilgrastim) PA Ribasphere (ribavirin) PA Neumega (oprelvekin) Rilutek (riluzole) PA Neupogen (filgrastim) PA Rituxan (rituximab) PA Nexavar (sorafenib) PA Roferon-A (interferon alfa-2a) PA Norditropin (somatropin) PA Saizen (somatropin) PA Novantrone (mitoxantrone) PA Samsca (tolvaptan) PA Novoseven RT (Factor VIIa) Sandostatin (octreotide) PA Nplate (romiplostim) PA Sandostatin Depot (octreotide depot) PA Nutropin (somatropin) PA Sensipar (cinacalcet) PA Nutropin AQ (somatropin) PA Serostim (somatropin) PA Omnitrope (somatropin) PA Simponi (golimumab) PA Orencia (abatacept) PA Soliris (eculizumab) PA Orfadin (nitisinone) PA Somatuline Depot (lanreotide) PA Panretin (alitretinoin 0.1% gel) PA Somavert (pegvisomant) PA PEG-Intron (peginterferon alfa-2b) PA Soriatane (acitretin ) PA Pegasys (peginterferon alfa-2a) PA Sprycel (dasatinib) PA Privigen (immune globulin) PA Stelara (ustekinumab) PA Procrit (erythropoietin) PA Sucraid (sacrosidase) PA Profilnine SD (Factor IX complex) Sutent (sunitinib) PA Specialty drugs include both brand-name drug and any generic equivalent. List is subject to change without notice. Page 5 PA Prior Authorization based on clinical criteria required prior to payment 2011-Sept

Paramount Medicaid Formularies Specialty Pharmacy Alphabetical Listing Brand Name (generic) criteria Brand Name (generic) criteria Sylatron (peginterferon alfa-2b) PA Vesanoid (tretinoin) PA Synagis (palivizumab) PA Victrelis (boceprevir) PA Tarceva (erlotinib) PA Virazole (ribavirin) PA Targretin (bexarotene) PA Vivaglobin (Subcut. immune globulin) PA Tasigna (nilotinib) PA Vivitrol (naltrexone inj.) Temodar (temozolomide) PA Wilate (Factor VIII/vWF(human)) Tev-tropin (somatropin) PA Xeloda (capecitabine) PA Thalomid (thalidomide) PA Xenazine (tetrabenazine) PA Thymoglobulin (immune globulin (rabbit)) Xyntha (Factor VIII) Toposar (etoposide) Xeomin (incobotulinumtoxin A) PA Tracleer (bosentan) PA Xolair (omalizumab) PA Tykerb (lapatinib) PA Xyrem (sodium oxybate) PA Tysabri (natalizumab) PA Zavesca (miglustat) PA Tyvaso (treprostinil) PA Zemaira (alpha-1 proteinase inhibitor) PA Vandetanib (vandetanib) PA Zolinza (vorinostat) PA Ventavis (iloprost) PA Zorbtive (somatropin) PA Specialty drugs include both brand-name drug and any generic equivalent. List is subject to change without notice. Page 6 PA Prior Authorization based on clinical criteria required prior to payment 2011-Sept